About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
EJNMMI Research
›
Top Articles
EJNMMI Research
2.9
(top 20%)
impact factor
1.1K
(top 20%)
papers
18.9K
(top 10%)
citations
54
(top 10%)
h
-index
3.1
(top 20%)
impact factor
1.3K
all documents
20.4K
doc citations
79
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
EJNMMI Research
2015
250
2
Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from 18F-FDG PET/CT images
EJNMMI Research
2017
194
3
Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects
EJNMMI Research
2011
149
4
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
EJNMMI Research
2018
144
5
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
EJNMMI Research
2017
140
6
Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT
EJNMMI Research
2013
137
7
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
EJNMMI Research
2014
137
8
A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer
EJNMMI Research
2012
134
9
Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres
EJNMMI Research
2013
129
10
IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms
EJNMMI Research
2017
125
11
Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare
EJNMMI Research
2012
124
12
Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
EJNMMI Research
2019
121
13
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique
EJNMMI Research
2012
120
14
Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis
EJNMMI Research
2014
118
15
Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy
EJNMMI Research
2015
118
16
A dual tracer 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT pilot study for detection of cardiac sarcoidosis
EJNMMI Research
2016
112
17
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors
EJNMMI Research
2012
107
18
Novel 89Zr cell labeling approach for PET-based cell trafficking studies
EJNMMI Research
2015
107
19
Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour
EJNMMI Research
2016
104
20
Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
EJNMMI Research
2012
100
21
18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)
EJNMMI Research
2011
99
22
Radiofluorination using aluminum-fluoride (Al18F)
EJNMMI Research
2013
98
23
The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG
EJNMMI Research
2013
96
24
Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT/CT
EJNMMI Research
2013
92
25
The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
EJNMMI Research
2015
91
26
[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
EJNMMI Research
2015
88
27
Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
EJNMMI Research
2012
86
28
Performance evaluation of the next generation solid-state digital photon counting PET/CT system
EJNMMI Research
2018
83
29
64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
EJNMMI Research
2015
82
30
Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
EJNMMI Research
2013
81
31
Comparison of four 11C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176—based on recent publications that measured specific-to-non-displaceable ratios
EJNMMI Research
2017
80
32
For avid glucose tumors, the SUV peak is the most reliable parameter for [18F]FDG-PET/CT quantification, regardless of acquisition time
EJNMMI Research
2016
79
33
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
EJNMMI Research
2011
78
34
PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy
EJNMMI Research
2012
78
35
Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
EJNMMI Research
2016
78
36
Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?
EJNMMI Research
2017
76
37
Nuclear imaging of inflammation: homing-associated molecules as targets
EJNMMI Research
2013
75
38
Nanobody: a promising toolkit for molecular imaging and disease therapy
EJNMMI Research
2021
75
39
Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activation
EJNMMI Research
2011
73
40
Optimized dose regimen for whole-body FDG-PET imaging
EJNMMI Research
2013
73
41
Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models
EJNMMI Research
2016
71
42
Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT
EJNMMI Research
2013
67
43
In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106
EJNMMI Research
2013
66
44
Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT
EJNMMI Research
2017
64
45
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
EJNMMI Research
2015
63
46
Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
EJNMMI Research
2015
60
47
Longitudinal analysis of bone metabolism using SPECT/CT and 99mTc-diphosphono-propanedicarboxylic acid: comparison of visual and quantitative analysis
EJNMMI Research
2016
60
48
Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner
EJNMMI Research
2012
58
49
Pretargeting of internalizing trastuzumab and cetuximab with a 18F-tetrazine tracer in xenograft models
EJNMMI Research
2017
58
50
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
EJNMMI Research
2018
58
site/software ©
exaly
; All materials licenced under
CC by-SA
.